Antiga et al. also reported fewer CD4+CD25brightFoxP3+ cells in SSc patients naïve to any systemic treatment compared with healthy controls and with patients having other common immune-mediate dermatoses (psoriasis, atopic dermatitis) (57). This evidence concerns the gene CD4 and systemic sclerosis.